Standardized and axially vascularized calcium phosphate-based implants for segmental mandibular defects: A promising proof of concept. (December 2022)

• Record Type: Journal Article
• Authors: Paré, Arnaud; Charbonnier, Baptiste; Veziers, Joëlle; Vignes, Caroline; Dutilleul, Maeva; De Pinieux, Gonzague; Laure, Boris; Bossard, Adeline; Saucet-Zerbib, Annaëlle; Touzot-Jourde, Gwenola; Weiss, Pierre; Corre, Pierre; Gauthier, Olivier; Marchat, David
• Is Part Of: Acta biomaterialia. Volume 154(2022)
• Page Start: 626
• Page End: 640
• Publication Date: 2022-12
• Subjects: Calcium phosphates -- Additive manufacturing -- Segmental mandibulectomy -- Bone regeneration -- Surgical model; Biomedical materials -- Periodicals; 610.28
• DOI: 10.1016/j.actbio.2022.09.071
• Languages: English
• ISSNs: 1742-7061

Abstract

Abstract: The reconstruction of massive segmental mandibular bone defects (SMDs) remains challenging even today; the current gold standard in human clinics being vascularized bone transplantation (VBT). As alternative to this onerous approach, bone tissue engineering strategies have been widely investigated. However, they displayed limited clinical success, particularly in failing to address the essential problem of quick vascularization of the implant. Although routinely used in clinics, the insertion of intrinsic vascularization in bioengineered constructs for the rapid formation of a feeding angiosome remains uncommon. In a clinically relevant model (sheep), a custom calcium phosphate-based bioceramic soaked with autologous bone marrow and perfused by an arteriovenous loop was tested to regenerate a massive SMD and was compared to VBT (clinical standard). Animals did not support well the VBT treatment, and the study was aborted 2 weeks after surgery due to ethical and animal welfare considerations. SMD regeneration was successful with the custom vascularized bone construct. Implants were well osseointegrated and vascularized after only 3 months of implantation and totally entrapped in lamellar bone after 12 months; a healthy yellow bone marrow filled the remaining space. Statement of significance: Regenerative medicine struggles with the generation of large functional bone volume. Among them segmental mandibular defects are particularly challenging to restore. The standard of care, based on bone free flaps, still displays ethical and technical drawbacks (e.g., donor site morbidity). Modern engineering technologies (e.g., 3D printing, digital chain) were combined to relevant surgical techniques to provide a pre-clinical proof of concept, investigating for the benefits of such a strategy in bone-related regenerative field. Results proved that a synthetic-biologics-free approach is able to regenerate a critical size segmental mandibular defect of 15 cm 3 in a relevant preclinical model, mimicking real life scenarii of segmental mandibular defect, with a full physiological regeneration of the defect after 12 months. Graphical abstract: Image, graphical abstract